Zoekresultaten - "CHA2DS2-VASc"

Thromboprophylaxis in atrial fibrillation: correct interpretation and effective use of CHA2DS2-VASc and HAS-BLED scores door Mateusz Wawrzeńczyk, Maria Kotulska, Aleksandra Suchenia, Agnieszka Dzido, Krzysztof Lachowski

Connect to this object online.

The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study door Alaa Quisi, Gökhan Alıcı, Hazar Harbalıoğlu, Ömer Genç, Fahri Er, Samir Allahverdiyev, Abdullah Yıldırım, Ibrahim Halil Kurt

Connect to this object online.

Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score door Po-Han Chen BS, Mark Schwade MD, Gyanendra Sharma MD, Vincent J. B. Robinson MD

Connect to this object online.

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation door Roberto Carnevale, Daniele Pastori, Mariangela Peruzzi, Elena De Falco, Isotta Chimenti, Giuseppe Biondi-Zoccai, Ernesto Greco, Antonino G. M. Marullo, Cristina Nocella, Francesco Violi, Pasquale Pignatelli, Camilla Calvieri, Giacomo Frati

Connect to this object online.

Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation door Akdag S, Simsek H, Sahin M, Akyol A, Duz R, Babat N

Connect to this object online.

Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation door Mohanad Yasir Radeef

Connect to this object online.

Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation door Mohanad Y. Al-Radeef

Connect to this object online.

Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHA2DS2-VASc Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism door Fan Q, Gao L, Wang Z, Ndjana Lessomo FY, Wang G

Connect to this object online.

Association of neutrophil/lymphocyte ratio and CHA2DS2-VASc score with left atrial thrombus in patients who are candidates for percutaneous mitral balloon valvuloplasty door Fatih Kahraman

Connect to this object online.

Association of neutrophil/lymphocyte ratio and CHA2DS2-VASc score with left atrial thrombus in patients who are candidates for percutaneous mitral balloon valvuloplasty door Orhan Maden, Kevser G Balci, Mustafa M Balci, Serdar Kuyumcu, Hatice Selçuk, Mehmet T Selçuk

Connect to this object online.

Scorul CHA2DS2VASC se asociază cu riscul de deces la pacienții cu tahicardie ventriculară dezvoltată tardiv post-infarct. door Lilia David, Aurel Grosu

Connect to this object online.

Antitrombotik berdasarkan skor CHA2DS2-VASc dan skor HAS BLED terhadap pola pengobatan pada pasien stroke iskemik dengan fibrilasi atrium door Rizaldy Taslim Pinzon, Gusti Ayu Putu Ika Bella Saptaning Astyari, Lidwina Tarigan

Connect to this object online.

Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction door Çağrı Zorlu, Cemal Köseoğlu

Connect to this object online.

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? door I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva

Connect to this object online.

Evolution of CHA₂DS₂-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation door A. O. Rubanenko

Connect to this object online.

Analysis of Variables Associated with Positive Micro-Embolic Signals Detected by Transcranial Doppler in Patients with Atrial Fibrillation and Their Predictive Value for Embolic Ri... door Xu Y, Dong ZZ, Jiang LJ, Zhang CX, Dong GY

Connect to this object online.

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE door I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman

Connect to this object online.

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE door I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman

Connect to this object online.

Thrombus of left atrium and/or its appendage in nonvalvular atrial fibrillation: echocardiographic and laboratory risk factors, capabilities for prediction and correction door I. A. Zaigraev, I. S. Yavelov

Connect to this object online.

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) door O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov

Connect to this object online.